908 Devices Inc. (MASS) Financial Ratios
8 years of historical data (2018–2025) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
30Y Low75.8·High75.8
P/B Ratio
↓
2.19
↑+23% vs avg
5yr avg: 1.78
30Y Low0.7·High3.4
ROE
↑
15.1%
↓+188% vs avg
5yr avg: -17.2%
30Y Low-52%·High15%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
MASS Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
908 Devices Inc. trades at 15.0x earnings, 54% above its 5-year average of 9.7x, sitting at the 100th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a discount of 33%.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $302M | $204M | $75M | $362M | $240M | $723M | $312M | — | — |
| Enterprise Value | $206M | $108M | $38M | $247M | $71M | $520M | $175M | — | — |
| P/E Ratio → | 14.96 | 9.72 | — | — | — | — | — | — | — |
| P/S Ratio | 5.37 | 3.64 | 1.26 | 7.20 | 5.12 | 17.14 | 11.61 | — | — |
| P/B Ratio | 2.19 | 1.42 | 0.65 | 2.19 | 1.26 | 3.37 | 2.25 | — | — |
| P/FCF | — | — | — | — | — | — | 75.78 | — | — |
| P/OCF | — | — | — | — | — | — | 75.62 | — | — |
P/E links to full P/E history page with 30-year chart
MASS EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.92 | 0.63 | 4.91 | 1.52 | 12.32 | 6.51 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | 42.46 | — | — |
MASS Profitability
Margins and return-on-capital ratios measuring operating efficiency
908 Devices Inc. earns an operating margin of -70.1%. Operating margins have expanded from -85.1% to -70.1% over the past 3 years, signaling improving operational efficiency. ROE of 15.1% indicates solid capital efficiency.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 50.6% | 50.6% | 50.2% | 50.4% | 55.5% | 55.0% | 55.5% | 45.3% | 56.2% |
| Operating Margin | -70.1% | -70.1% | -128.7% | -85.1% | -75.5% | -52.3% | -21.6% | -67.6% | -29.2% |
| Net Profit Margin | 34.7% | 34.7% | -121.1% | -72.5% | -71.6% | -52.5% | -47.7% | -74.4% | -34.2% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | 15.1% | 15.1% | -51.6% | -20.4% | -16.6% | -12.5% | -33.8% | — | — |
| ROA | 11.2% | 11.2% | -39.8% | -16.3% | -13.3% | -10.1% | -11.8% | -40.9% | -27.2% |
| ROIC | -47.5% | -47.5% | -90.2% | -89.0% | -160.5% | -253.6% | — | — | — |
| ROCE | -27.2% | -27.2% | -48.7% | -21.2% | -15.1% | -10.7% | -5.8% | -44.5% | -28.0% |
MASS Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $113M exceeds total debt of $17M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.12 | 0.12 | 0.06 | 0.04 | 0.10 | 0.10 | 0.16 | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.67 | -0.33 | -0.70 | -0.89 | -0.95 | -0.99 | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | -33.33 | — | — |
| Interest Coverage | — | — | — | -212.19 | -259.18 | -44.62 | -5.96 | -7.94 | -5.57 |
Net cash position: cash ($113M) exceeds total debt ($17M)
MASS Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
908 Devices Inc.'s current ratio of 4.24x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 3.86x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 7.71x to 4.24x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.24 | 4.24 | 4.10 | 7.71 | 11.22 | 17.05 | 15.78 | 4.72 | 3.61 |
| Quick Ratio | 3.86 | 3.86 | 3.45 | 7.04 | 10.56 | 16.51 | 15.36 | 3.86 | 2.87 |
| Cash Ratio | 3.32 | 3.32 | 2.77 | 6.46 | 9.80 | 15.10 | 14.70 | 2.96 | 1.49 |
| Asset Turnover | — | 0.30 | 0.37 | 0.25 | 0.19 | 0.16 | 0.15 | 0.48 | 0.79 |
| Inventory Turnover | 2.14 | 2.14 | 1.84 | 1.67 | 1.66 | 2.40 | 2.62 | 1.88 | 2.74 |
| Days Sales Outstanding | — | 73.57 | 77.29 | 65.32 | 78.16 | 143.34 | 92.63 | 103.15 | 104.86 |
MASS Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
908 Devices Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 6.7% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 6.7% | 10.3% | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | 1.3% | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $39M | $34M | $32M | $31M | $28M | $5M | $8M | $8M |
Peer Comparison
Compare MASS with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 MASSYou | $302M | 15.0 | — | — | 50.6% | -70.1% | 15.1% | -47.5% | — |
 MASI | $9B | -63.8 | 27.7 | 47.3 | 61.9% | 20.5% | -17.1% | 16.5% | 1.6 |
 WAT | $23B | 32.6 | 21.5 | 42.3 | 57.8% | 28.2% | 29.3% | 20.3% | 1.3 |
 A | $34B | 26.0 | 19.9 | 29.2 | 52.4% | 21.3% | 20.6% | 13.5% | 1.9 |
 TMO | $176B | 26.8 | 19.0 | 28.0 | 37.7% | 18.2% | 13.1% | 7.5% | 3.8 |
 BRKR | $7B | -291.5 | 18.4 | 153.7 | 45.9% | 6.9% | -0.4% | 4.4% | 4.5 |
 LECO | $15B | 29.1 | 19.5 | 27.8 | 36.3% | 16.9% | 37.2% | 22.7% | 1.6 |
 DHR | $124B | 34.9 | 18.2 | 23.6 | 60.9% | 20.9% | 7.1% | 5.9% | 2.4 |
 RGEN | $7B | 147.0 | 52.4 | 75.9 | 47.1% | 8.1% | 2.4% | 2.2% | 5.0 |
 AZTA | $855M | -15.2 | 13.8 | 22.3 | 45.5% | -1.9% | -3.2% | -0.5% | 2.2 |
 IDXX | $45B | 43.7 | 31.6 | 43.1 | 61.8% | 31.6% | 66.2% | 42.5% | 0.7 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 8 years · Updated daily
See MASS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MASS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MASS vs MASI
Side-by-side business, growth, and profitability comparison vs Masimo Corporation.
Start ComparisonMASS — Frequently Asked Questions
Quick answers to the most common questions about buying MASS stock.
What is 908 Devices Inc.'s P/E ratio?
908 Devices Inc.'s current P/E ratio is 15.0x. The historical average is 9.7x. This places it at the 100th percentile of its historical range.
What is 908 Devices Inc.'s ROE?
908 Devices Inc.'s return on equity (ROE) is 15.1%. The historical average is -20.0%.
Is MASS stock overvalued?
Based on historical data, 908 Devices Inc. is trading at a P/E of 15.0x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are 908 Devices Inc.'s profit margins?
908 Devices Inc. has 50.6% gross margin and -70.1% operating margin.